silybin has been researched along with Protein Aggregation, Pathological in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bongiorno, C; D'Urso, L; Di Fabio, G; Diomede, L; Galati, C; Grasso, G; La Rosa, C; Lolicato, F; Milardi, D; Monaco, I; Romanucci, V; Romeo, M; Salmona, M; Sciacca, MFM; Spinella, N; Zarrelli, A | 1 |
Chen, X; Duan, S; Fang, S; Gu, H; Guan, X; Huang, J; Li, Q; Lin, R; Liu, X; Sun, X; Xu, J; Yan, Y; Yao, Z; Zhang, T | 1 |
Biedermann, D; Chondrogianni, N; Filippopoulou, K; Křen, V; Lefaki, M; Papaevgeniou, N; Paraskevopoulou, A | 1 |
3 other study(ies) available for silybin and Protein Aggregation, Pathological
Article | Year |
---|---|
Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry.
Topics: Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Blotting, Western; Caenorhabditis elegans; Dose-Response Relationship, Drug; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Molecular Dynamics Simulation; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregation, Pathological; Protein Conformation; Silybin; Silymarin | 2017 |
Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Dentate Gyrus; Female; Male; Mice, Transgenic; Nerve Regeneration; Phytotherapy; Protein Aggregation, Pathological; Rats, Sprague-Dawley; Silybin; Silybum marianum; Silymarin | 2015 |
2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound.
Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Line; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Glucose Transport Proteins, Facilitative; Humans; Longevity; Oxidative Stress; Protective Agents; Protein Aggregation, Pathological; Silybin; Silymarin | 2017 |